The global oligonucleotide CDMO market is projected to expand from USD 2.98 billion in 2026 to USD 8.499 billion by 2036, growing at an 11.05% CAGR. Growth is fueled by rising demand for nucleic acid-based therapeutics including antisense oligonucleotides and siRNA, with pharmaceutical companies outsourcing development and manufacturing to specialized CDMOs. Advances in synthesis and purification technologies, alongside expanding therapeutic applications and geographic market growth—especially in Asia-Pacific—are key drivers. Leading companies are investing in capacity and technology to meet increasing demand and support commercialization.
The global oligonucleotide CDMO market size and forecast provide context for health-sector trading on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 13, 2026 22:52 WIB: out of 150 priced US health-sector stocks, 56 rose and 94 fell. Notable movers include OSCR (Oscar Health Inc) at USD 30.66 with a -4.01% change and 100% sell order activity, CGC (Canopy Growth Corp) at USD 0.55 with a -3.80% change and 86% sell order activity, and DFTX (Definium Therapeutics Inc.) at USD 31.76 with a -3.76% change and 100% buy order activity.
Solo, a company specializing in privacy-preserving human verification, has integrated its SDK into JellyJelly, a social video app co-founded by Venmo's co-founder. This integration ensures that every JellyJelly account belongs to a real, unique perso...
The U.S. market for AI-enabled ophthalmic diagnostic devices is projected to grow from $72.5 million in 2026 to $267.2 million by 2033, expanding at a 20.5% CAGR. Growth is driven by rising diabetes-related eye diseases, FDA clearances for autonomous...
The global medical display monitors market, valued at $2.8 billion in 2025, is projected to grow to $4.0 billion by 2033 with a CAGR of 4.6%. Growth is fueled by rising adoption of digital imaging systems, demand for accurate diagnostics, and healthc...
Oppenheimer downgraded Enovix from Outperform to Perform as the company expands production in South Korea and shifts focus to drone and smart-eyewear customers. Enovix reported a 38% revenue increase to $11 million in Q3 but saw its adjusted loss wid...
On November 12, 2026, Nokia executive Pallavi Mahajan acquired 89 shares of Nokia Corporation at a price of €7.63 per share. This insider purchase is officially reported under EU Market Abuse Regulation Article 19. Such transactions by company execut...
